'Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector?

G Melino1, M Piacentini

  • 1Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Dept. Experimental Medicine, University of Rome Tor Vergata, Italy. gerry-melino@uniromaZ.it

FEBS Letters
|July 25, 1998
PubMed

Insights

Tissue transglutaminase (tTG) is a multifunctional enzyme crucial for regulating apoptosis. Recent findings reveal its complex role in cell death pathways, extending beyond its traditional function in protein crosslinking.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Mechanisms

Background:

  • Apoptosis involves morphological changes regulated by proteins like tissue transglutaminase (tTG).
  • tTG was initially recognized for its role in crosslinking proteins to prevent cellular leakage and reduce inflammation.
  • Emerging evidence suggests tTG has a more intricate function in the upstream regulation of apoptosis.

Purpose of the Study:

  • To explore the multifaceted role of tissue transglutaminase (tTG) in the regulation of apoptosis.
  • To elucidate the complex molecular mechanisms underlying tTG's involvement in cell death pathways.

Main Methods:

  • Analysis of tTG's function as a GTP-binding protein in signal transduction.
  • Investigation of tTG's substrate specificity in cytosolic and nuclear compartments.
  • Examination of tTG's regulation by calcium ions, GTP, S-nitrosylation, and polyamines.

Main Results:

  • tTG functions as a GTP-binding protein, participating in signal transduction.
  • tTG exhibits specific binding and crosslinking of particular cytosolic and nuclear substrates.
  • tTG's activity is modulated by Ca2+, GTP, S-nitrosylation, and polyamines, indicating precise control.

Conclusions:

  • The role of tissue transglutaminase (tTG) in regulating the balance between cell survival and death is complex.
  • tTG is a key regulator in the apoptotic machinery, with functions beyond simple crosslinking.
  • tTG's specific interactions and regulatory mechanisms highlight its critical involvement in apoptosis.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...